Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

Singapore · Delayed Price · Currency is SGD · Price in USD

3.200

-0.120 (-3.61%)

Mar 4, 2026, 4:59 PM SGT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Chinese Patent Medicine	5.66B	5.84B	5.65B	4.67B	4.37B
Chinese Patent Medicine Growth	-3.07%	3.26%	21.04%	6.86%	-9.82%
Western Medicine	1.19B	1.70B	1.78B	1.60B	1.65B
Western Medicine Growth	-29.75%	-4.84%	11.74%	-2.99%	-3.05%
Others	443.15M	673.08M	796.26M	626.90M	575.27M
Others Growth	-34.16%	-15.47%	27.02%	8.97%	33.02%
Total	7.29B	8.21B	8.23B	6.89B	6.59B
Total Growth	-11.13%	-0.31%	19.43%	4.59%	-5.51%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	7.26B	8.16B	8.20B	6.86B	6.57B
China Growth	-11.09%	-0.44%	19.53%	4.36%	-5.34%
Overseas	36.73M	44.88M	33.74M	33.91M	18.28M
Overseas Growth	-18.15%	33.00%	-0.48%	85.49%	-43.00%
Total	7.29B	8.21B	8.23B	6.89B	6.59B
Total Growth	-11.13%	-0.31%	19.43%	4.59%	-5.51%

Source: S&P Global Market Intelligence.